Abstract
This paper describes the development of nonmyeloablative marrow transplant programs that have little toxicity in a canine model and their translation to patients with malignant and nonmalignant hematological diseases.
Original language | English (US) |
---|---|
Pages (from-to) | 372-376 |
Number of pages | 5 |
Journal | Annals of the New York Academy of Sciences |
Volume | 872 |
DOIs | |
State | Published - 1999 |
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Neuroscience(all)
- History and Philosophy of Science